Skip to content
2000
Volume 8, Issue 1
  • ISSN: 1871-5214
  • E-ISSN: 1875-6018

Abstract

Although, β-lactams have historically been viewed as a class of antimicrobials, in the last few decades their role as inhibitors of bacterial enzymes has been expanded. Their inhibitory activity is based on their ability to acylate enzymes, majority of which have serine as nucleophile in the active site. In addition to being inhibitors of bacterial enzymes, β-lactams also inhibit viral and mammalian serine enzymes. Recently, a blinded screening of 1,040 FDA approved drugs and nutritional compounds, has demonstrated an additional utility both in vitro and in vivo of β-lactam antibiotics (penicillins and cephalosporins) as protectors against neuroexcitotoxicity. This neuroprotection is associated with increases in the glial-associated reuptake protein, GLT1, suggesting that β-lactam's neuroprotective effects may be mediated by an increase in glutamate removal from the synapse. The focus of this review is on the evaluation of the potential of β-lactam antibiotics as neuroprotective agents.

Loading

Article metrics loading...

/content/journals/aiamc/10.2174/187152109787047823
2009-01-01
2025-05-08
Loading full text...

Full text loading...

/content/journals/aiamc/10.2174/187152109787047823
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test